Literature DB >> 15106297

Certification of polio eradication: process and lessons learned.

Joseph Smith1, Rose Leke, Anthony Adams, Rudolf H Tangermann.   

Abstract

Since the 1988 World Health Assembly resolution to eradicate poliomyelitis, considerable progress has been made towards interrupting the transmission of wild poliovirus globally. A formal process for the certification of polio eradication was established on the basis of experience gained during smallpox eradication. Independent groups of experts were designated at the global, regional, and country levels to conduct the process. The main requirements for the global certification of the eradication of wild poliovirus are the absence of wild poliovirus, isolated from suspect polio cases, healthy individuals, or environmental samples, in all WHO regions for a period of at least three years in the presence of high-quality, certification-standard surveillance and the containment of all wild poliovirus stocks in laboratories. Three WHO regions--the Region of the Americas (1994), Western Pacific Region (2000), and European Region (2002)--have already been certified free of indigenous wild poliovirus. Eradication and certification activities are progressing well in the three endemic regions (African, Eastern Mediterranean, and South-East Asia). Several challenges remain for the certification of polio eradication: the need for even closer coordination of certification activities between WHO regions, the verification of laboratory containment, the development of an appropriate mechanism to verify the absence of circulating vaccine-derived polioviruses in the future, and the maintenance of polio-free status in certified regions until global certification.

Entities:  

Mesh:

Year:  2004        PMID: 15106297      PMCID: PMC2585869     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  15 in total

1.  Comorbidity profile of poliomyelitis survivors in a Chinese population: a population-based study.

Authors:  Jiunn-Horng Kang; Herng-Ching Lin
Journal:  J Neurol       Date:  2011-01-30       Impact factor: 4.849

2.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

Review 3.  Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine.

Authors:  Myron M Levine
Journal:  BMC Biol       Date:  2010-10-04       Impact factor: 7.431

4.  Reorganization of Active Surveillance of Acute Flaccid Paralysis (AFP) in Emilia-Romagna, Italy: a two-step Public Health intervention.

Authors:  Lucia Palandri; Mariana Morgado; Maria Eugenia Colucci; Paola Affanni; Roberta Zoni; Sandra Mezzetta; Assunta Bizzarro; Licia Veronesi
Journal:  Acta Biomed       Date:  2020-04-10

5.  Has Wild Poliovirus Been Eliminated from Nigeria?

Authors:  Michael Famulare
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

6.  Suspension of mandatory vaccination and public health preserving: Rovigo local health unit experience after appliance of Veneto regional law 7/2007.

Authors:  M Cattarin; M Bellè; M Bergamini; L Gallo
Journal:  J Prev Med Hyg       Date:  2013-09

7.  National, Regional and Global Certification Bodies for Polio Eradication: A Framework for Verifying Measles Elimination.

Authors:  S Deblina Datta; Rudolf H Tangermann; Susan Reef; W William Schluter; Anthony Adams
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

8.  An evaluation of the sensitivity of acute flaccid paralysis surveillance for poliovirus infection in Australia.

Authors:  Rochelle E Watkins; P Anthony J Martin; Heath Kelly; Ben Madin; Charles Watson
Journal:  BMC Infect Dis       Date:  2009-09-30       Impact factor: 3.090

9.  Crippling Violence: Conflict and Incident Polio in Afghanistan.

Authors:  Alison Norris; Kevin Hachey; Andrew Curtis; Margaret Bourdeaux
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

Review 10.  Nanotechnology in vaccine delivery.

Authors:  Laura J Peek; C Russell Middaugh; Cory Berkland
Journal:  Adv Drug Deliv Rev       Date:  2008-02-07       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.